Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,428.00
Bid: 12,432.00
Ask: 12,436.00
Change: -82.00 (-0.66%)
Spread: 4.00 (0.032%)
Open: 12,556.00
High: 12,562.00
Low: 12,420.00
Prev. Close: 12,510.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Taiwan says China blocked deal with BioNTech for COVID-19 shots

Wed, 26th May 2021 08:36

(Adds Taiwanese official seeking U.S. and EU help)

By Yimou Lee and Ben Blanchard

TAIPEI, May 26 (Reuters) - Taiwan directly accused China for
the first time on Wednesday of blocking a deal with Germany's
BioNTech SE for COVID-19 vaccines, in an escalating
war of words after Beijing offered the shots to the island via a
Chinese company.

Taiwan has millions of shots on order, from AstraZeneca Plc
and Moderna Inc, but has received only slightly
more than 700,000 to date, and has only been able to vaccinate
about 1% of its population as COVID-19 cases surge.

While Taiwan has previously said it had been unable to sign
a final contract with BioNTech, it had only implied that Chinese
pressure was to blame.

China claims Taiwan as its territory and frequently puts
pressure on countries and firms to curtail their dealings with
the island.

President Tsai Ing-wen told a meeting of her ruling
Democratic Progressive Party that orders for the AstraZeneca and
Moderna shots had been "smoothly" booked.

"As for Germany's BioNTech, we were close to completing the
contract with the original German plant, but because of China's
intervention, up to now there's been no way to complete it," she
said.

Taiwan, which has a population of more than 23 million
people, had bought nearly 30 million shots, Tsai said, without
giving details.

BioNTech, which sells its vaccine in partnership with Pfizer
Inc, declined to comment on Tsai's remarks, but added
"we are supportive of global vaccine supply".

China has denied trying to block vaccines for Taiwan and has
offered to provide them to the island as a goodwill gesture.

APPEALS FOR U.S., EU ASSISTANCE

Lily L.W. Hsu, secretary-general of Taiwan's Foreign
Ministry, called the Chinese offer "very divisive."

At an online event hosted by the German Marshall Fund of the
United States that also involved a U.S. and an EU official, Hsu
said Taiwan was developing its own vaccine, but the earliest
that would be ready for use was July. She repeated calls Taiwan
has made for U.S and EU assistance.

"Because of the recent outbreak we desperately need vaccines
... we do need assistance in getting vaccines before our
domestic vaccine is ready for use, she said.

The top U.S. diplomat in Taipei, Brent Christensen, said on
Wednesday he was confident Taiwan could control its spike in
COVID-19 cases, noting its infection numbers remained quite low.
He said the United States and Taipei were in talks on vaccines
but did not say shots were on the way.

China's Shanghai Fosun Pharmaceutical Group Co Ltd
said on Saturday it was willing to provide Taiwan
with BioNTech COVID-19 vaccines.

Fosun signed a deal with BioNTech to exclusively develop and
commercialise the vaccine developed using BioNTech's mRNA
technology in mainland China, Hong Kong, Macau and Taiwan.

But Tsai said the island would only buy directly from the
original manufacturers, or discuss purchases with them via the
COVAX global vaccine sharing scheme.

"Only by negotiating with the original manufacturer can you
obtain the original manufacturer's direct guarantee and
responsibility for quality and safety, so as to avoid legal and
political risks," she said.

Fosun did not respond to requests for comment.

China's foreign ministry said Taiwan's channels to receive
vaccines from them were "smooth", while China's Taiwan Affairs
Office said Taipei was using excuses to stop the shots.

China was "happy to see" Fosun's willingness to provide
vaccines to Taiwan, the Chinese office added.

Several Taiwan politicians have said the need for the Fosun
shots was so urgent the government should bring them in.

But Taiwan's Health Minister Chen Shih-chung told a daily
news briefing Taiwan had seen no supporting documentation about
Fosun's version of the vaccine.

"Bring out the official documents and we can talk about it
again."
(Reporting by Ben Blanchard and Yimou Lee in Taipei and David
Brunnstrom and Michael Martina in Washington; Editing by
Christopher Cushing, Robert Birsel and Bill Berkrot)

More News
Today 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

Read more
Today 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

Read more
Today 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

Read more
Today 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

Read more
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.